Epigenomic regulation of bile acid metabolism: Emerging role of transcriptional cofactors

Molecular and Cellular Endocrinology

Volumn 368, Issue 1-2, 2013, Pages 59-70

  Smith, Zachary ^a   Ryerson, Daniel ^a   Kemper, Jongsook Kim ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Chromatin remodeling; Coregulators; FGF15; Histone modification; Liver metabolism; Post translational modification

Indexed keywords

BILE ACID; BRG1 PROTEIN; BRM PROTEIN; DOXORUBICIN; E1A ASSOCIATED P300 PROTEIN; G PROTEIN SUPPRESSOR 2; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTONE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 7; HISTONE G9A; MIXED LINEAGE LEUKEMIA PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN 3; MIXED LINEAGE LEUKEMIA PROTEIN 4; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN CARM1; PROTEIN PRMT1; PROTEIN TYROSINE PHOSPHATASE SHP; SIRTUIN 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BILE ACID METABOLISM; BILE ACID SYNTHESIS; BSEP GENE; CHOLESTASIS; DETOXIFICATION; DIABETES MELLITUS; ENDOCRINE FUNCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; EPIGENETICS; GENE; GENETIC REGULATION; HUMAN; LIVER CANCER; LIVER METABOLISM; NEGATIVE FEEDBACK; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BILE ACIDS AND SALTS; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; HISTONE DEACETYLASES; HUMANS; LIPID METABOLISM; LIVER; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 84875272845     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.04.008     Document Type: Review

References (111)

1. Aalfs J., Kingston R. What does chromatin remodeling mean?. TIBS 2000, 251742:548-555.
2. Ananthanarayanan M., Li S., Balasubramaniyan N., Suchy F.J., Walsh M.J. Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1. J. Biol. Chem. 2004, 279:54348-54357.
3. Ananthanarayanan M., Li Y., Surapureddi S., Balasubramaniyan N., Ahn J., Goldstein J.A., Suchy F.J. Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G771-81.
4. Bae Y., Kemper J.K., Kemper B. Repression of CAR-mediated transactivation of CYP2B genes by the orphan nuclear receptor, short heterodimer partner (SHP). DNA Cell Biol. 2004, 231:81-91.
5. Balakrishnan A., Bleeker F.E., Lamba S., Rodolfo M., Daniotti M., Scarpa A., van Tilborg A.A., Leenstra S., Zanon C., Bardelli A. Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma. Cancer Res. 2007, 67:3545-3550.
6. Bavner A., Sanyal S., Gustafsson J.A., Treuter E. Transcriptional corepression by SHP: molecular mechanisms and physiological consequences. Trends Endocrinol. Metab. 2005, 16:478-488.
7. Bolden J.E., Peart M.J., Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 2006, 5:769-784.
8. Boulias K., Katrakili N., Bamberg K., Underhill P., Greenfield A., Talianidis I. Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP. EMBO J. 2005, 24:2624-2633.
9. Boulias K., Talianidis I. Functional role of G9a-induced histone methylation in small heterodimer partner-mediated transcriptional repression. Nucleic Acids Res. 2004, 32:6096-6103.
10. Bricambert J., Miranda J., Benhamed F., Girard J., Postic C., Dentin R. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J. Clin. Invest. 2010, 120:4316-4331.
11. Bultman S., Gebuhr T., Yee D., La Mantia C., Nicholson J., Gilliam A., Randazzo F., Metzger D., Chambon P., Crabtree G., Magnuson T. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol. Cell 2000, 6:1287-1295.
12. Bungard D., Fuerth B.J., Zeng P.Y., Faubert B., Maas N.L., Viollet B., Carling D., Thompson C.B., Jones R.G., Berger S.L. Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science 2010, 329:1201-1205.
13. Cai, L., Tu, B.P., 2011. On acetyl-CoA as a gauge of cellular metabolic state. Cold Spring Harb. Symp. Quant. Biol. http://dx.doi.org/10.1101/sqb.2011.76.010769.
14. Cai S.Y., Boyer J.L. FXR: a target for cholestatic syndromes?. Expert Opin. Ther. Targets 2006, 10:409-421.
15. Cariou B., Staels B. FXR: a promising target for the metabolic syndrome?. Trends Pharmacol. Sci. 2007, 28:236-243.
16. Chanda D., Park J.H., Choi H.S. Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner. Endocr. J. 2008, 55:253-268.
17. Chanda D., Xie Y.B., Choi H.S. Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation. Nucleic Acids Res. 2010, 38:4607-4619.
18. Chiang J.Y. Bile acids: regulation of synthesis. J. Lipid Res. 2009, 50:1955-1966.
19. Choi M., Moschetta A., Bookout A.L., Peng L., Umetani M., Holmstrom S.R., Suino-Powell K., Xu H.E., Richardson J.A., Gerard R.D., Mangelsdorf D.J., Kliewer S.A. Identification of a hormonal basis for gallbladder filling. Nat. Med. 2006, 12:1253-1255.
20. Chopra A.R., Kommagani R., Saha P., Louet J.F., Salazar C., Song J., Jeong J., Finegold M., Viollet B., DeMayo F., Chan L., Moore D.D., O'Malley B.W. Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption. Cell. Metab. 2011, 13:35-43.
21. Choudhuri S., Cui Y., Klaassen C.D. Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol. Appl. Pharmacol. 2010, 245:378-393.
22. Cui J.Y., Choudhuri S., Knight T.R., Klaassen C.D. Genetic and epigenetic regulation and expression signatures of glutathione S-transferases in developing mouse liver. Toxicol. Sci. 2010, 116:32-43.
23. Cui J.Y., Gunewardena S.S., Rockwell C.E., Klaassen C.D. ChIPing the cistrome of PXR in mouse liver. Nucleic Acids Res. 2010, 38:7943-7963.
24. Fang S., Miao J., Xiang L., Ponugoti B., Treuter E., Kemper J.K. Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism. Mol. Cell. Biol. 2007, 27:1407-1424.
25. Fang S., Tsang S., Jones R., Ponugoti B., Yoon H., Wu S.Y., Chiang C.M., Willson T.M., Kemper J.K. The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP. J. Biol. Chem. 2008, 283:35086-35095.
26. Farhana L., Dawson M.I., Leid M., Wang L., Moore D.D., Liu G., Xia Z., Fontana J.A. Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor. Cancer Res. 2007, 67:318-325.
27. Feng D., Liu T., Sun Z., Bugge A., Mullican S.E., Alenghat T., Liu X.S., Lazar M.A. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 2011, 331:1315-1319.
28. Fiorucci S., Mencarelli A., Palladino G., Cipriani S. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol. Sci. 2009, 30:570-580.
29. Fiorucci S., Rizzo G., Donini A., Distrutti E., Santucci L. Targeting farnesoid X receptor for liver and metabolic disorders. Trends Mol. Med. 2007, 13:298-309.
30. Flowers S., Nagl N.G., Beck G.R., Moran E. Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. J. Biol. Chem. 2009, 284:10067-10075.
31. Gobinet J., Carascossa S., Cavailles V., Vignon F., Nicolas J.C., Jalaguier S. SHP represses transcriptional activity via recruitment of histone deacetylases. Biochemistry (NY) 2005, 44:6312-6320.
32. Goo Y.H., Sohn Y.C., Kim D.H., Kim S.W., Kang M.J., Jung D.J., Kwak E., Barlev N.A., Berger S.L., Chow V.T., Roeder R.G., Azorsa D.O., Meltzer P.S., Suh P.G., Song E.J., Lee K.J., Lee Y.C., Lee J.W. Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins. Mol. Cell. Biol. 2003, 23:140-149.
33. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., Galardi C., Wilson J.G., Lewis M.C., Roth M.E., Maloney P.R., Wilson T.M., Kliewer S.A. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 2000, 61660:517-526.
34. Guo G.L., Lambert G., Negishi M., Ward J.M., Brewer H.B., Kliewer S.A., Gonzalez F.J., Sinal C.J. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem. 2003, 278:45062-45071.
35. Haberland M., Montgomery R.L., Olson E.N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 2009, 10:32-42.
36. Hassan A.H., Neely K.E., Vignali M., Reese J.C., Workman J.L. Promoter targeting of chromatin-modifying complexes. Front. Biosci. 2001, 6:D1054-64.
37. Houten S.M., Watanabe M., Auwerx J. Endocrine functions of bile acids. EMBO J. 2006, 25:1419-1425.
38. Huang J., Iqbal J., Saha P.K., Liu J., Chan L., Hussain M.M., Moore D.D., Wang L. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology 2007, 46:147-157.
39. Hylemon P.B., Zhou H., Pandak W.M., Ren S., Gil G., Dent P. Bile acids as regulatory molecules. J. Lipid Res. 2009, 50:1509-1520.
40. Ihunnah C.A., Jiang M., Xie W. Nuclear receptor PXR, transcriptional circuits and metabolic relevance. Biochim. Biophys. Acta 2011, 1812:956-963.
41. Inagaki T., Choi M., Moschetta A., Peng L., Cummins C.L., McDonald J.G., Luo G., Jones S.A., Goodwin B., Richardson J.A., Gerard R.D., Repa J.J., Mangelsdorf D.J., Kliewer S.A. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005, 2:217-225.
42. Iyer A., Fairlie D.P., Brown L. Lysine acetylation in obesity, diabetes and metabolic disease. Immunol. Cell Biol. 2011, 90:39-46.
43. Jakobsson T., Venteclef N., Toresson G., Damdimopoulos A.E., Ehrlund A., Lou X., Sanyal S., Steffensen K.R., Gustafsson J.A., Treuter E. GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus. Mol. Cell 2009, 34:510-518.
44. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
45. Johansson L., Bavner A., Thomsen J.S., Farnegardh M., Gustafsson J.A., Treuter E. The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors. Mol. Cell. Biol. 2000, 20:1124-1133.
46. Johansson L., Thomsen J.S., Damdimopoulos A.E., Spyrou G., Gustafsson J.A., Treuter E. The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERa and ERb. J. Biol. Chem. 1999, 274:345-353.
47. Kadam S., Emerson B.M. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol. Cell 2003, 11:377-389.
48. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1:15-25.
49. Kanamaluru D., Xiao Z., Fang S., Choi S., Kim D., Veenstra T.D., Kemper J.K. Arginine methylation by PRMT5 at a naturally-occurring mutation site is critical for liver metabolic regulation by Small Heterodimer Partner. Mol. Cell Biol. 2011, 31:1540-1550.
50. Kemper J.K., Xiao Z., Ponugoti B., Miao J., Fang S., Kanamaluru D., Tsang S., Wu S., Chiang C.M., Veenstra T.D. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 2009, 10:392-404.
51. Kemper J., Kim H., Miao J., Bhalla S., Bae Y. Role of a mSin3A-Swi/Snf chromatin remodeling complex in the feedback repression of bile acid biosynthesis by SHP. Mol. Cell Biol. 2004, 24:7707-7719.
52. Kemper J.K. Regulation of FXR transcriptional activity in health and disease: emerging roles of FXR cofactors and post-translational modifications. Biochim. Biophys. Acta 2011, 1812:842-850.
53. Kim D.H., Kim J., Lee J.W. Requirement for MLL3 in p53 regulation of hepatic expression of small heterodimer partner and bile acid homeostasis. Mol. Endocrinol. 2011, 25:2076-2083.
54. Kim D.H., Lee J., Lee B., Lee J.W. ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity. Mol. Endocrinol. 2009, 23:1556-1562.
55. Kir S., Beddow S.A., Samuel V.T., Miller P., Previs S.F., Suino-Powell K., Xu H.E., Shulman G.I., Kliewer S.A., Mangelsdorf D.J. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 2011, 331:1621-1624.
56. Klaassen C.D., Lu H., Cui J.Y. Epigenetic regulation of drug processing genes. Toxicol. Mech. Methods 2011, 21:312-324.
57. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
58. Lee F.Y., Lee H., Hubbert M.L., Edwards P.A., Zhang Y. FXR, a multipurpose nuclear receptor. Trends Biochem. Sci. 2006, 31:572-580.
59. Lee J., Kim D.H., Lee S., Yang Q.H., Lee D.K., Lee S.K., Roeder R.G., Lee J.W. A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4. Proc. Natl. Acad. Sci. USA 2009, 106:8513-8518.
60. Lee S., Roeder R.G., Lee J.W. Roles of histone H3-lysine 4 methyltransferase complexes in NR-mediated gene transcription. Prog. Mol. Biol. Transl. Sci. 2009, 87:343-382.
61. Lee Y., Dell H., Dowhan D.H., Hadzopoulou-Cladaras M., Moore D.D. The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. Mol. Cell Biol. 2000, 20:187-195.
62. Lee Y., Moore D.D. Dual mechanism for repression of the monomeric orphan receptor liver receptor homologous protein-1 (LRH-1) by the orphan small heterodimer partner (SHP). J. Biol. Chem. 2002, 277:2463-2467.
63. Lefebvre P., Cariou B., Lien F., Kuipers F., Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 2009, 89:147-191.
64. Li T., Chanda D., Zhang Y., Choi H.S., Chiang J.Y. Glucose stimulates cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes. J. Lipid Res. 2010, 51:832-842.
65. Li X., Zhang S., Blander G., Tse J.G., Krieger M., Guarente L. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol. Cell 2007, 28:91-106.
66. Lu T.T., Makishima M., Repa J.J., Schoonjans K., Kerr T.A., Auwerx J., Mangelsdorf D.J. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 2000, 6:507-515.
67. Miao J., Choi S.E., Seok S.M., Yang L., Zuercher W.J., Xu Y., Willson T.M., Xu H.E., Kemper J.K. Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes. Mol. Endocrinol. 2011, 25:1159-1169.
68. Miao J., Fang S., Lee J., Comstock C., Knudsen K.E., Kemper J.K. Functional specificities of Brm and Brg-1 Swi/Snf ATPases in the feedback regulation of hepatic bile acid biosynthesis. Mol. Cell Biol. 2009, 29:6170-6181.
69. Minucci S., Pelicci P.G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 2006, 6:38-51.
70. Mitro N., Godio C., De Fabiani E., Scotti E., Galmozzi A., Gilardi F., Caruso D., Vigil Chacon A.B., Crestani M. Insights in the regulation of cholesterol 7alpha-hydroxylase gene reveal a target for modulating bile acid synthesis. Hepatology 2007, 46:885-897.
71. Modica S., Moschetta A. Nuclear bile acid receptor FXR as pharmacological target: are we there yet?. FEBS Lett. 2006, 580:5492-5499.
72. Moschetta A., Bookout A.L., Mangelsdorf D.J. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat. Med. 2004, 10:1352-1358.
73. Narlikar G.J., Fan H.Y., Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002, 108:475-487.
74. Park Y.J., Kim S.C., Kim J., Anakk S., Lee J.M., Tseng H.T., Yechoor V., Park J., Choi J.S., Jang H.C., Lee K.U., Novak C.M., Moore D.D., Lee Y.K. Dissociation of diabetes and obesity in mice lacking orphan nuclear receptor small heterodimer partner. J. Lipid Res. 2011, 52:2234-2244.
75. Park Y.J., Qatanani M., Chua S.S., LaRey J.L., Johnson S.A., Watanabe M., Moore D.D., Lee Y.K. Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis. Hepatology 2008, 47:1578-1586.
76. Peterson C.L., Workman J.L. Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr. Opin. Genet. Dev. 2000, 10:187-192.
77. Ponugoti B., Kim D.H., Xiao Z., Smith Z., Miao J., Zang M., Wu S.Y., Chiang C.M., Veenstra T.D., Kemper J.K. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J. Biol. Chem. 2010, 285:33959-33970.
78. Reyes J.C., Barra J., Muchardt C., Camus A., Babinet C., Yaniv M. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J. 1998, 17:6979-6991.
79. Rice J.C., Allis C.D. Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr. Opin. Cell Biol. 2001, 13:263-273.
80. Rizzo G., Renga B., Antonelli E., Passeri D., Pellicciari R., Fiorucci S. The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes. Mol. Pharmacol. 2005, 68:551-558.
81. Roberts C.W., Orkin S.H. The SWI/SNF complex - chromatin and cancer. Nat. Rev. Cancer. 2004, 4:133-142.
82. Rodgers J.T., Lerin C., Gerhart-Hines Z., Puigserver P. Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett. 2008, 582:46-53.
83. Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M., Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005, 434:113-118.
84. Rosenfeld M.G., Lunyak V.V., Glass C.K. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 2006, 20:1405-1428.
85. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 2003, 72:137-174.
86. Russell D.W. Nuclear orphan receptors control cholesterol catabolism. Cell 1999, 97:539-542.
87. Saha A., Wittmeyer J., Cairns B.R. Chromatin remodelling: the industrial revolution of DNA around histones. Nat. Rev. Mol. Cell Biol. 2006, 7:437-447.
88. Sanyal S., Bavner A., Haroniti A., Nilsson L.M., Lundasen T., Rehnmark S., Witt M.R., Einarsson C., Talianidis I., Gustafsson J.A., Treuter E. Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis. Proc. Natl. Acad. Sci. USA 2007, 104:15665-15670.
89. Sassone-Corsi P. Minireview: NAD+, a circadian metabolite with an epigenetic twist. Endocrinology 2012, 153:1-5.
90. Seol W., Choi H., Moore D.D. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 1996, 272:1336-1339.
91. Staels B., Kuipers F. Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Drugs 2007, 67:1383-1392.
92. Strobeck M.W., Reisman D.N., Gunawardena R.W., Betz B.L., Angus S.P., Knudsen K.E., Kowalik T.F., Weissman B.E., Knudsen E.S. Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling. J. Biol. Chem. 2002, 277:4782-4789.
93. Suchy F.J., Ananthanarayanan M. Bile salt excretory pump: biology and pathobiology. J. Pediatr. Gastroenterol. Nutr. 2006, 43(Suppl 1):S10-6.
94. Swigut T., Wysocka J. H3K27 demethylases, at long last. Cell 2007, 131:29-32.
95. Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu. Rev. Pharmacol. Toxicol. 2009, 49:243-263.
96. Tachibana M., Sugimoto K., Nozaki M., Ueda J., Ohta T., Ohki M., Fukuda M., Takeda N., Niida H., Kato H., Shinkai Y. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 2002, 16:1779-1791.
97. Teperino R., Schoonjans K., Auwerx J. Histone methyl transferases and demethylases; can they link metabolism and transcription?. Cell. Metab. 2010, 12:321-327.
98. Thomas C., Gioiello A., Noriega L., Strehle A., Oury J., Rizzo G., Macchiarulo A., Yamamoto H., Mataki C., Pruzanski M., Pellicciari R., Auwerx J., Schoonjans K. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009, 10:167-177.
99. Thomas C., Pellicciari R., Pruzanski M., Auwerx J., Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat. Rev. Drug Discov. 2008, 7:678-693.
100. Trauner M., Boyer J.L. Bile salt transporters: molecular characterization, function, and regulation. Physiol. Rev. 2003, 83:633-671.
101. Venteclef N., Jakobsson T., Ehrlund A., Damdimopoulos A., Mikkonen L., Ellis E., Nilsson L.M., Parini P., Janne O.A., Gustafsson J.A., Steffensen K.R., Treuter E. GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. Genes Dev 2010, 24:381-395.
102. Wagner M., Zollner G., Trauner M. Nuclear receptors in liver disease. Hepatology 2011, 53:1023-1034.
103. Wang L., Liu J., Saha P., Huang J., Chan L., Spiegelman B., Moore D.D. The orphan nuclear receptor SHP regulates PGC-1alpha expression and energy production in brown adipocytes. Cell Metab. 2005, 2:227-238.
104. Watanabe M., Houten S.M., Mataki C., Christoffolete M.A., Kim B.W., Sato H., Messaddeq N., Harney J.W., Ezaki O., Kodama T., Schoonjans K., Bianco A.C., Auwerx J. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006, 439:484-489.
105. Workman J.L., Kingston R.E. Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem. 1998, 67:545-579.
106. Xie W., Radominska-Pandya A., Shi Y., Simon C., Nelson M., Ong E., Waxman D., Evans R. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic cile acids. Proc. Natl. Acad. Sci. USA 2001, 98:3375-3380.
107. Xie Y., Ke S., Ouyang N., He J., Xie W., Bedford M.T., Tian Y. Epigenetic regulation of transcriptional activity of pregnane X receptor by protein arginine methyltransferase 1. J. Biol. Chem. 2009, 284:9199-9205.
108. Zhang J., Kalkum M., Chait B.T., Roeder R.G. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 2002, 9:611-623.
109. Zhang Y., Edwards P.A. FXR signaling in metabolic disease. FEBS Lett. 2008, 582:10-18.
110. Zhang Y., Hagedorn C.H., Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim. Biophys. Acta 2011, 1812:893-908.
111. Zhang Y., Soto J., Park K., Viswanath G., Kuwada S., Abel E.D., Wang L. Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth. Mol. Cell Biol 2010, 30:1341-1356.